Video Experimental Relacionado
Updated: Mar 2, 2026
08:46
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
54.2K
Avances en Terapias Celulares para Tumores Sólidos: Un Camino para Superar Obstáculos Biológicos, Operacionales y
Kedar Kirtane1, Michael Kalos2, Rocky Billups3
1Head & Neck-Endocrine Oncology, Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL, USA.
Transplantation and cellular therapy
|February 28, 2026
Resumen
El desarrollo de terapias celulares para tumores sólidos requiere estrategias innovadoras para superar desafíos biológicos y operacionales. Un marco colaborativo enfatiza la estandarización, la fabricación regional y la recalibración regulatoria para un mayor acceso de los pacientes.
Área de la Ciencia:
- Oncología
- Inmunoterapia
- Terapia Celular
Sus antecedentes:
- Las terapias celulares han transformado el tratamiento de las neoplasias hematológicas.
- Las aplicaciones emergentes son prometedoras para los tumores sólidos, pero enfrentan desafíos únicos.
Objetivo del estudio:
- Proponer un marco para avanzar en el desarrollo de terapias celulares en tumores sólidos.
- Abordar los obstáculos biológicos, operacionales, de fabricación y regulatorios.
Principales métodos:
- Informado por la Cumbre 2025 sobre Avances en Terapia Celular para Tumores Sólidos.
- Propuso un modelo operacional colaborativo que enfatiza la estandarización y los centros regionales.
- Destacó la necesidad de recalibración regulatoria y participación de los pagadores.
Principales resultados:
- Identificó desafíos clave: heterogeneidad de antígenos, toxicidad, inmunosupresión y accesibilidad.
- Esbozó estrategias: redes de centros y radios, derivaciones tempranas y capacitación mejorada para proveedores.
- Abogó por el almacenamiento de materiales, enfoques regulatorios basados en datos y acreditación adaptada.
Conclusiones:
- La colaboración interdisciplinaria es vital para el acceso equitativo y seguro a la terapia celular en tumores sólidos.
- Las innovaciones operacionales y regulatorias son cruciales para la escalabilidad y la garantía de calidad.
- La terapia celular tiene un potencial más allá de las neoplasias hematológicas, lo que requiere un desarrollo estratégico.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
02:49Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K